Ferroptosis: a novel pharmacological mechanism against multiple myeloma

Ferroptosis: a novel pharmacological mechanism against multiple myeloma

BackgroundMultiple myeloma (MM) is a malignant disease characterized by the clonal proliferation of plasma cells in the bone marrow. Currently incurable, relapse and drug resistance remain significant challenges, necessitating the exploration of novel anti-MM agents. Ferroptosis, a form of cell deat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jingbo Shi, Yitong Lu, Wenjian Wei, Guodong Ma, Changnian Li, Lulu Li, Yaru Wang, Yan Wang, Ruirong Xu, Siyuan Cui
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Pharmacology
Subjects:	multiple myeloma ferroptosis pharmacological mechanism natural products antitumor effects
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1606804/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antitumor treatment and cardiohemodynamics in patients with multiple myeloma depending on renal function
by: B. B. Samura, et al.
Published: (2020-08-01)

Clinical case of giant extramedullar plasmacytoma in a patient with multiple myeloma
by: G. Sh. Safuanova, et al.
Published: (2023-12-01)

A novel defined risk signature of ferroptosis-related lncRNAs for predicting prognosis, immune infiltration, and chemotherapy response in multiple myeloma
by: Wei Yu, et al.
Published: (2025-02-01)

Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma
by: Wenjiao Tang, et al.
Published: (2024-07-01)

Elotuzumab in the treatment of patients with refractory and relapsed multiple myeloma Experience of the Lapino Clinical Hospital Oncohematology Department
by: Yu. E. Ryabukhina, et al.
Published: (2023-12-01)

Pharmacological effects of gastrodin: Insight into neurological diseases and mechanism in ferroptosis and pyroptosis
by: Xue Zheng, et al.
Published: (2025-03-01)

Clinical features of multiple myeloma with bone plasmacytomas
by: E. A. Mamaeva, et al.
Published: (2023-03-01)

Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma—A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone
by: Tobias S. Slørdahl, et al.
Published: (2025-02-01)

DIAGNOSTIC OF NONSECRETORY MULTIPLE MYELOMA (CLINICAL CASE)
by: N. T. Vatutin, et al.
Published: (2017-03-01)

Prevalence of multiple myeloma in patients on hemodialysis programs
by: David Garrido, et al.
Published: (2025-03-01)

Multiple Myeloma Case Developed During the Use of the Teriparatide
by: Zehra Erdemir, et al.
Published: (2022-04-01)

False-Positive Galactomannan Test Results in Multiple Myeloma
by: Shingen Nakamura, et al.
Published: (2025-04-01)

The Multiple Myeloma
by: Keivan Daneshvar, et al.
Published: (2024-03-01)

Pitfalls in the pathological diagnosis of multiple myeloma
by: V. V. Baykov
Published: (2022-11-01)

Chromothripsis in Treatment Resistance in Multiple Myeloma
by: Kyoung Joo Lee, et al.
Published: (2017-09-01)

Whole-body low-dose computed tomography in primary patients with multiple myeloma
by: A. M. Danilina, et al.
Published: (2023-05-01)

Genomic characteristics and prognostic correlations in Chinese multiple myeloma patients
by: Xi Chen, et al.
Published: (2025-03-01)

Unexpected hope for a multiple myeloma patient
by: Minodora Cezarina Onisâi, et al.
Published: (2020-10-01)

Nestin in multiple myeloma: emerging insights into a potential therapeutic target
by: Yingmiao Wu, et al.
Published: (2025-07-01)

Enhancing prognosis in multiple myeloma bone disease: insights from a retrospective analysis of surgical interventions
by: Xiangjun Shi, et al.
Published: (2024-12-01)

Research progress of the immunosuppressive tumor microenvironment in multiple myeloma
by: Yue WANG, et al.
Published: (2025-08-01)

Multiple Myeloma Involving Left Hemicranium
by: Jutty Parthiban, et al.
Published: (2022-12-01)

Neutrophilic hyperleukocytosis in the multiple myeloma onset
by: I. G. Rekhtina, et al.
Published: (2022-07-01)

Cariohemodynamics in patients with multiple myeloma depending on renal function
by: B. B. Samura, et al.
Published: (2019-12-01)

Cutaneous involvement in multiple myeloma. A rare entity
by: L. Rapparini, et al.
Published: (2025-02-01)

Angiogenesis and multiple myeloma: Exploring prognostic potential of adrenomedullin
by: Angelos Giannakoulas, et al.
Published: (2024-09-01)

Exploration of the Prognostic Markers of Multiple Myeloma Based on Cuproptosis‐Related Genes
by: Xiao‐Han Gao, et al.
Published: (2025-03-01)

The characteristics of Korean elderly multiple myeloma patients aged 80 years or over
by: Sang Hwan Lee, et al.
Published: (2025-01-01)

Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions
by: Kara I. Cicero, et al.
Published: (2025-01-01)

Efficiency of pomalidomide therapy in patients with multiple myeloma refractory to lenalidomide
by: I. G. Rekhtina, et al.
Published: (2019-04-01)

Infectious complications in patients with multiple myeloma on first chemotherapy cycle
by: A. A. Novikova, et al.
Published: (2018-10-01)

Clinical profile of multiple myeloma in South India
by: Chemban Fousad, et al.
Published: (2018-01-01)

Herpes zoster prophylaxis: Essential for treating newly diagnosed multiple myeloma patients
by: Wen‐Ying Lin, et al.
Published: (2023-02-01)

Multiple cystic swelling: Initial presentation of multiple myeloma
by: Kumar Sunil, et al.
Published: (2010-03-01)

Anaplastic Multiple Myeloma Presenting as Acute Liver Failure: A Case Report
by: Yasmin O. Ali, et al.
Published: (2025-01-01)

How to Diagnose, Treat, and Monitor Treatment Response in Patients with Multiple Myeloma
by: Wulyo Rajabto, et al.
Published: (2022-09-01)

Results of multiple myeloma treatment with bortezomib
by: T. I. Pospelova, et al.
Published: (2022-11-01)

Subglottic extramedullary plasmacytoma in a patient with multiple myeloma
by: Eva M. Ruis de Gauna Martin, et al.
Published: (2013-03-01)

Progress of immune senescence in multiple myeloma treatment resistance
by: Yanan Jia, et al.
Published: (2025-03-01)

Mechanism of Brucea javanica against multiple myeloma via TNF-NF-κB signaling
by: Yuan Wang, et al.
Published: (2025-07-01)